SEER News and Press, Seer Inc. From 03/01/21

REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Monday, Mar...

REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating in the upcoming Cowen 41 st Annual Healthcare Conference. Seer’s ma...

REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Deep Nishar and Mostafa Ronaghi, Ph.D. to serve on its Board of Directors, effective Februar...

REDWOOD CITY, Calif. , Feb. 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the closing of an underwritten public offering of 3,750,000 shares of Class A common stock at a public offering price of $67...

Seer (SEER) has priced upsized public offering of 3.75M Class A common shares (1.65M of which are being offered for sale by Seer and 2.1M by selling stockholders) at $67.00/share.The selling stockholders have granted the underwriters an option to purchase additional 562.5K shares.Closing date...

REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten public offering of 3,750,000 shares of Class A common stock (1,650,000 of which are being offe...

REDWOOD CITY, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed underwritten public offering of 3,500,000 shares of Class A common stock (1,400,000 of which a...

Seer ([[SEER]]) have signed a non-exclusive commercial agreement with Bruker, one of the world’s leading analytical instrumentation companies.This agreement will enable Seer to market the timsTOF Pro mass spectrometer system together with its Proteograph Product Suite.“This part...

REDWOOD CITY, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that it has signed a non-exclusive commercial agreement with Thermo Fisher Scientific, a world leader in serving sci...

REDWOOD CITY, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with Bruker Corporation, one of the world’s leadin...